Review Article
Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach
Table 1
MicroRNA involved in diabetic atherosclerosis.
| miR type | Animal model | Mechanism | Target gene | Reference |
| miR33 | STZ-induced diabetic Ldlr−/− mice | Increased macrophages and lipid content | ABCA1 | [37] | miR 125b | Type 2 diabetic db/db mice | Increased inflammatory gene expression | SUV39H1 | [38] | miR 200 | Type 2 diabetic db/db mice | Increased inflammatory gene expression | Zeb1 | [39] | miR 504 | Type 2 diabetic db/db mice | Vascular smooth muscle phenotype change | Grb10 | [40] | miR138 | Type 2 diabetic db/db mice | Vascular smooth muscle phenotype change | SIRT1 | [41] |
|
|
ABCA1: ATP-binding cassette transporter A1; SIRT1: silent information regulator 1.
|